FDA — authorised 31 January 2002
- Application: BLA125031
- Marketing authorisation holder: AMGEN
- Local brand name: NEULASTA
- Indication: SYRINGE
- Status: approved
🇺🇸 pegfiligrastim in United States
FDA authorised pegfiligrastim on 31 January 2002
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is pegfiligrastim approved in United States?
Yes. FDA authorised it on 31 January 2002.
Who is the marketing authorisation holder for pegfiligrastim in United States?
AMGEN holds the US marketing authorisation.